Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... However, longer-term effects are less clear. Dr. Shamini Jain, from the UCLA Division of Cancer Prevention and Control Research, and Dr. Paul Mills, from the Department of Psychiatry ... Disease, Clinical Trial Research, Dementia, Mental Disorder, Oncology, Psychiatry, Therapy, Treatment, Springer.This article was prepared by NewsRx Health & Science ...
2009 NOV 29 ... according to study published online November 10 in the Journal of the National Cancer Institute.Erythropoiesis-stimulating agents (i.e., erythropoietin and ... Blood Transfusion, Cancer, Chemotherapy, Deep Vein Thrombosis, Drug Therapy, Erythropoiesis, Erythropoietin, Hematology, Medical Device, Oncology, Pulmonary ...
2009 NOV 28 ... in," said McElvany, a school superintendent from Wewoka, Okla. treated for prostate cancer. "Few people can say that during cancer treatment. The folks here made me feel like I ... The first group of patients have completed treatment at the ProCure Proton Therapy Center in Oklahoma City, the sixth center in the country to provide proton therapy, an ...
2009 NOV 28 ... worldwide are infected with HCV. HCV can cause chronic liver disease, cirrhosis and cancer, and is the leading cause of liver transplant in the United States.Inhibitex ... in Phase I studies, supports the potential of FV-100 as a highly potent, once-daily oral therapy to reduce the incidence and severity of shingles-related symptoms, including acute pain ...
2009 NOV 24 ... provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer ... the tools doctors need to administer intra-operative and office-based radiation therapy safely and effectively - for all cancer patients. The company's flagship product, ...
2009 NOV 29 ... European health associations in their combined battle against cardiovascular disease, cancer, respiratory illness, diabetes and kidney disease. In June this year experts from ten ... thromboembolic stroke as a result of atrial fibrillation receive effective prophylactic therapy."According to the World Stroke Organization, stroke now accounts for almost ...
2009 NOV 25 ... Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary ... management, the use of radioiodine remnant ablation, thyroid hormone suppression therapy, as well as long-term surveillance based on ultrasound, other imaging modalities, and ...
Subject: Mary Ann Liebert, Inc./Genetic Engineering News
2009 NOV 29 ... according to a new study published online November 10 in the Journal of the National Cancer Institute.In this study in mice, Tom Van Maerken, M.D., Center for Medical ... by inhibiting MDM2 in human trials.Keywords: Pediatrics, Anticancer Therapy, Antitumor Activity, Cancer, Hematology, Neuroblastoma, Oncology, Small Molecule ...
2009 NOV 29 ... its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares ... trying to find out whether AIDS viruses can be used as gene delivery vehicles in gene therapy. Therefore, it is crucial for them to know where exactly HIV integrates into the genetic ...
Subject: Helmholtz Association of German Research Centres
2009 NOV 29 ... important for developing new strategies for combating AD and other diseases, including cancer and diabetes, in which the PKA and GSK-3 signaling pathways are centrally involved," ... Disease, Enzymes, Kinase, Mental Health, Neurodegenerative, Pathology, Synthase, Therapy, Treatment, Research.This article was prepared by NewsRx Health & Science ...
2009 NOV 27 ... (1m) was found to be the most potent derivative inhibiting the cell growth of several cancer cell lines in the lower nanomolar range."Putey and colleagues published ... City:Orleans, Country:France, City:Orleans, Country:France, Life Sciences, Therapy, Treatment, Antiproliferative Activity, Drug Development, Medicinal ...
2009 NOV 27 ... that could someday be used to treat a variety of diseases, especially multiple types of cancer."There is a pressing need for drugs that target transcription factors, both ... published in the November 12 issue of Nature, lays the foundation for a new kind of therapy aimed directly at a critical human protein - one of a few thousand so-called ...
2009 NOV 28 ... syndrome, said Dao Pan, Ph.D., a researcher in the Division of Experimental Hematology/Cancer Biology at Cincinnati Children's and the study's principal author. It also is the ... Academy of Sciences.The study suggests a new approach to molecular gene therapy and a much-needed improved treatment option for children with Hurler's syndrome, said ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 29 ... son to Bert Schutte in Maastricht, who had developed a BrdU detection system for use in cancer therapy. Maybe he could help De Goeij Junior find evidence of cell division in his ...
2009 NOV 23 ... product candidates span a range of pain indications, including neuropathic pain, cancer pain, post-operative pain, cluster headache, chronic daily headache and arthritis. This ... Neuropathic Pain, Oncology, Pain Management, Pharmaceuticals, Post-operative Pain, Therapy, Treatment, Winston Pharmaceuticals Inc. This article was prepared by Pain ...
2009 NOV 29 ... women worldwide, killing more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDS and malaria combined.However, the risk for women is ... underrepresentation is particularly noticeable in the fields of cholesterol-lowering therapy, ischaemic heart disease and heart failure.Professor Roberto Ferrari, ...
2009 NOV 23 ... of the Center for Sarcoma and Bone Oncology and the Ludwig Center at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of ZIOPHARM's Medical Advisory ... Sunitinib Maleate, Sutent, Synovial Sarcoma, Testicular Cancer, Testicular Diseases, Therapy, Treatment, U.S. Food and Drug Administration, Urology, ZIOPHARM Oncology Inc. ...
2009 NOV 23 ... seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, reported its financial results for the quarter ... Pre-Trials Research, Regulatory Actions, Sarcoma, Soft Tissue Sarcoma, Therapies, Therapy, Treatment, U.S. Food and Drug Administration, Women's Health, ZIOPHARM Oncology Inc. ...
